AXP

AMERICAN EXPRESS CO
2 filings tracked
financialscredit cardsLARGE ($10B-200B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

American Express is successfully evolving into a high-margin financial ecosystem, reporting a 15% increase in net income to $2.97 billion for the first quarter of 2026.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline growth, a concerning trend is emerging in the company's credit quality. Net write-off rates have climbed, with consumer and small business segments showing specific pressure.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every AXP filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing reveals a company at a crossroads between aggressive growth and emerging systemic risks. While the 15% net income surge and 9.3% revenue increase suggest a thriving business, the underlying credit metrics and legal headwinds introduce significant volatility. The tension between high-margin growth and rising default rates creates a complex outlook for investors. Ultimately, the impact of the filing suggests that while the premium brand remains a powerful moat, the cost of maintaining that moat is rising. Investors must now weigh the immediate benefits of capital returns against the long-term uncertainty of antitrust litigation and the potential for a regulatory-driven capital hit.

Selected Quarter

Core Takeaway

Amex is growing profitably, but the cost of credit and legal risk is accelerating.

Investor Lens

The trade-off between aggressive shareholder returns and rising credit risk.

Watch Next

The outcome of the Dutch and UK antitrust investigations.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.17Q1 '26 (10-K)+0.22Q2 '26 (10-Q)

Signal Timeline

3 of 6
Active Filters:Quarter: Q2 '26 (10-Q)
bullishApr 23

Net income grew 15% to $2.97 billion.

earnings beat
85%
bearishApr 23

Facing significant antitrust litigation and international probes.

regulatory action
70%
bullishApr 23

Returned $2.3 billion to shareholders through dividends and repurchases.

buyback
50%

Filing History

10-QApr 23, 2026
Expand Sequence

The Q1 2026 filing reveals a company at a crossroads between aggressive growth and emerging systemic risks. While the 15% net income surge and 9.3% revenue increase suggest a thriving business, the underlying credit metrics and legal headwinds introduce significant volatility. The tension between high-margin growth and rising default rates creates a complex outlook for investors. Ultimately, the impact of the filing suggests that while the premium brand remains a powerful moat, the cost of maintaining that moat is rising. Investors must now weigh the immediate benefits of capital returns against the long-term uncertainty of antitrust litigation and the potential for a regulatory-driven capital hit.

10-KFeb 6, 2026
Expand Sequence

The 2025 10-K presents a company at a crossroads between operational excellence and structural risk. While the core business is thriving with a 33.9% return on average equity and expanding margins, the financial architecture remains complex. The parent company's reliance on equity income from subsidiaries and the presence of massive, subjective liabilities create a risk profile that contrasts with the polished consumer-facing brand. Ultimately, the investment case hinges on whether the growth in agentic commerce and premium B2B services can outpace the costs of regulatory compliance and the inherent risks of its funding model. The company's aggressive capital return strategy suggests management confidence, but the liquidity buffer relative to total deposits remains a critical point of monitoring for investors.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.